Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness


Dateline City:


Historic Milestone Reflects Successful Collaboration Among MECTIZAN® Donation Program and Partners

WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada,
applauds the government of Colombia whose work with the MECTIZAN®
Donation Program and The Carter Center-sponsored Onchocerciasis
Elimination Program for the Americas led to today’s Pan American Health
Organization, the World Health Organization’s Regional Office for the
Americas (PAHO/WHO), verification of Colombia as the first country in
the world to eliminate the transmission of river blindness
(onchocerciasis), using MECTIZAN (i…